Imprimis Hit With Warning Letter Amidst Lawsuit

The FDA issued Imprimis Pharmaceuticals a warning letter after finding the firm made misleading claims about its eye care products on its website and social media, saying the violations created a public health concern.
Source: Drug Industry Daily